Fiduciary Trust Co Purchases Shares of 5,207 Relx Plc (NYSE:RELX)

Fiduciary Trust Co acquired a new position in shares of Relx Plc (NYSE:RELX - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 5,207 shares of the technology company's stock, valued at approximately $237,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. CENTRAL TRUST Co boosted its position in shares of Relx by 1,290.2% during the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock worth $26,000 after buying an additional 529 shares during the period. Transce3nd LLC acquired a new position in shares of Relx during the fourth quarter worth approximately $40,000. Sierra Ocean LLC acquired a new position in shares of Relx during the fourth quarter worth approximately $43,000. Brown Brothers Harriman & Co. boosted its position in shares of Relx by 218.5% during the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after buying an additional 662 shares during the period. Finally, Private Trust Co. NA boosted its position in shares of Relx by 19.2% during the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after buying an additional 199 shares during the period. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. The Goldman Sachs Group assumed coverage on Relx in a research report on Wednesday, March 26th. They set a "buy" rating for the company. Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. StockNews.com cut Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. Finally, Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Relx presently has an average rating of "Buy".

Relx Price Performance

NYSE:RELX traded up $0.49 during midday trading on Friday, hitting $54.53. 432,311 shares of the stock were exchanged, compared to its average volume of 707,376. Relx Plc has a one year low of $43.28 and a one year high of $55.21. The company has a market capitalization of $100.66 billion, a price-to-earnings ratio of 29.32, a P/E/G ratio of 2.73 and a beta of 0.86. The business has a 50-day moving average price of $51.14 and a two-hundred day moving average price of $48.92. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46.

Relx Increases Dividend

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be issued a dividend of $0.5586 per share. This is a boost from Relx's previous semi-annual dividend of $0.23. The ex-dividend date is Friday, May 9th. This represents a yield of 1.6%. Relx's payout ratio is presently 59.68%.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.